Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
159M
-
Number of holders
-
286
-
Total 13F shares, excl. options
-
112M
-
Shares change
-
+896K
-
Total reported value, excl. options
-
$5.68B
-
Value change
-
+$50.5M
-
Put/Call ratio
-
0.98
-
Number of buys
-
138
-
Number of sells
-
-111
-
Price
-
$50.87
Significant Holders of IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) as of Q2 2017
333 filings reported holding IONS - IONIS PHARMACEUTICALS INC - COMMON STOCK as of Q2 2017.
IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) has 286 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 112M shares
of 159M outstanding shares and own 70.47% of the company stock.
Largest 10 shareholders include FMR LLC (18.6M shares), Clearbridge Investments, LLC (11.8M shares), WELLINGTON MANAGEMENT GROUP LLP (10.5M shares), VANGUARD GROUP INC (9.86M shares), BAILLIE GIFFORD & CO (7.45M shares), BB BIOTECH AG (7.35M shares), BlackRock Inc. (6.82M shares), WADDELL & REED FINANCIAL INC (5.14M shares), STATE STREET CORP (2.96M shares), and OppenheimerFunds, Inc. (2.73M shares).
This table shows the top 286 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.